-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2024.
- Estrella Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 36.2M shares, a 3340% increase year-over-year.
- Estrella Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 27.1M shares, a 8765% increase from 2023.
- Estrella Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 306K shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)